Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

0Q6H

Hofseth Biocare Asa (0Q6H)

Hofseth Biocare Asa
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:0Q6H
DateTimeSourceHeadlineSymbolCompany
05/16/20241:00AMUK RegulatoryHofseth Biocare ASA: FIRST QUARTER 2024 FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
05/10/20247:30AMUK RegulatoryHofseth Biocare ASA: Annual General Meeting completedLSE:0Q6HHofseth Biocare Asa
04/19/20246:00AMUK RegulatoryHofseth Biocare ASA: NOTICE OF ANNUAL GENERAL MEETING 2024LSE:0Q6HHofseth Biocare Asa
04/19/20241:00AMUK RegulatoryHofseth Biocare ASA: HBC ANNUAL REPORT 2023LSE:0Q6HHofseth Biocare Asa
04/05/202411:08AMUK RegulatoryHofseth Biocare ASA: DISCLOSURE OF LARGE SHAREHOLDINGLSE:0Q6HHofseth Biocare Asa
03/21/20244:40AMUK RegulatoryHofseth Biocare ASA: UPDATED COMPANY PRESENTATIONLSE:0Q6HHofseth Biocare Asa
03/14/20246:12AMUK RegulatoryHofseth Biocare ASA: CHAIR KRISTIN FJELLBY GRUNG STEPS DOWNLSE:0Q6HHofseth Biocare Asa
02/09/20241:00AMUK RegulatoryHofseth Biocare ASA: FOURTH QUARTER 2023 AND FULL YEAR FINANCIAL REPORTLSE:0Q6HHofseth Biocare Asa
02/06/20248:56AMUK RegulatoryHofseth Biocare ASA: HBC Immunology Inc successfully completes first animal model of prostate cancer with FT-005 in combination with hormonal (anti-androgen) therapy demonstrating significant anti-tumour activityLSE:0Q6HHofseth Biocare Asa
 Showing the most relevant articles for your search:LSE:0Q6H